// App-Quantinova.ai

: Factors influencing Idiopathic Pulmonary Fibrosis (IPF) anti-fibrotic decisions in a single UK centre; patient and physician perspectives

Researchers

Presenter

  • Alexis Papadopoulos

Principal Investigators

  • Savvas Zannetos

  • Rachel Hoyles

Medical Centers

  • Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom,

  • Directorate General for European Programmes, Coordination and Development, Nicosia, Cyprus

Locations

  • United Kingdom

  • Cyprus

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved